Chargement en cours...
Effectiveness and Tolerability of Therapy With Once-Weekly Exenatide Versus Basal Insulin Among Injectable-Naive Patients With Type 2 Diabetes in a Real-World Setting in the United States
A propensity-matched cohort study compared injectable-naive patients with type 2 diabetes initiating exenatide once weekly (EQW) or basal insulin (BI), from 2012 through 2015, within a U.S. electronic health record database. A1C and weight were obtained as observed or multiply imputed values at base...
Enregistré dans:
| Publié dans: | Diabetes Spectr |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Diabetes Association
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5951230/ https://ncbi.nlm.nih.gov/pubmed/29773932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/ds16-0081 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|